Mark Poritz
Direttore Tecnico/Scientifico/R&S presso CO-DIAGNOSTICS, INC.
Posizioni attive di Mark Poritz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CO-DIAGNOSTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2022 | - |
Storia della carriera di Mark Poritz
Precedenti posizioni note di Mark Poritz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Idaho Molecular, Inc.
 Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Mark Poritz
| University of California | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CO-DIAGNOSTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Idaho Molecular, Inc.
Idaho Molecular, Inc. BiotechnologyHealth Technology Part of Co-Diagnostics, Inc., Idaho Molecular, Inc. is a biotechnology company that develops molecular diagnostics test devices. The company is based in South Salt Lake, UT. The CEO of the company is Kirk M. Ririe. Idaho Molecular was acquired by Co-Diagnostics, Inc. on December 31, 2021. | Health Technology |
- Borsa valori
- Insiders
- Mark Poritz
- Esperienza
